NasdaqGS - Delayed Quote • USD
Intuitive Surgical, Inc. (ISRG)
At close: April 25 at 4:00 PM EDT
Pre-Market: 6:18 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 23 | 23 |
| Avg. Estimate | 1.53 | 1.57 | 6.27 | 7.35 |
| Low Estimate | 1.48 | 1.47 | 6.16 | 6.87 |
| High Estimate | 1.61 | 1.63 | 6.54 | 7.75 |
| Year Ago EPS | 1.42 | 1.46 | 5.71 | 6.27 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 25 | 25 |
| Avg. Estimate | 1.97B | 1.99B | 8.01B | 9.28B |
| Low Estimate | 1.91B | 1.91B | 7.88B | 8.88B |
| High Estimate | 2.03B | 2.03B | 8.13B | 9.61B |
| Year Ago Sales | 1.74B | -- | 7.12B | 8.01B |
| Sales Growth (year/est) | 13.20% | -- | 12.50% | 15.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.33 | 1.41 | 1.48 | 1.41 |
| EPS Actual | 1.42 | 1.46 | 1.6 | 1.5 |
| Difference | 0.09 | 0.05 | 0.12 | 0.09 |
| Surprise % | 6.80% | 3.50% | 8.10% | 6.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.53 | 1.57 | 6.27 | 7.35 |
| 7 Days Ago | 1.56 | 1.58 | 6.25 | 7.32 |
| 30 Days Ago | 1.56 | 1.58 | 6.25 | 7.3 |
| 60 Days Ago | 1.56 | 1.58 | 6.25 | 7.32 |
| 90 Days Ago | 1.56 | 1.58 | 6.27 | 7.34 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 5 | 13 | 12 |
| Up Last 30 Days | 6 | 7 | 19 | 17 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 7 | 7 | 3 | 2 |
Growth Estimates
| CURRENCY IN USD | ISRG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 7.70% | -- | -- | 2.60% |
| Next Qtr. | 7.50% | -- | -- | 13.40% |
| Current Year | 9.80% | -- | -- | 5.20% |
| Next Year | 17.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.56% | -- | -- | 11.11% |
| Past 5 Years (per annum) | 10.21% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | BTIG: Buy to Buy | 4/19/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/19/2024 |
| Maintains | Jefferies: Hold to Hold | 4/19/2024 |
| Maintains | Baird: Outperform to Outperform | 4/19/2024 |
| Maintains | Stifel: Buy to Buy | 4/8/2024 |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 |
Related Tickers
RMD ResMed Inc.
183.42
-0.20%
RGEN Repligen Corporation
165.66
-1.31%
WST West Pharmaceutical Services, Inc.
368.18
-4.55%
BDX Becton, Dickinson and Company
230.48
-1.43%
BAX Baxter International Inc.
40.23
-1.71%
STAA STAAR Surgical Company
46.89
-1.94%
BNGO Bionano Genomics, Inc.
0.7590
-0.28%
HOLX Hologic, Inc.
75.71
-1.30%
ALC Alcon Inc.
78.84
-0.92%
COO The Cooper Companies, Inc.
89.93
-0.30%